Latest News of VYGR
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
By Yahoo! Finance |
1 month ago
Voyager Therapeutics reported strong quarterly results with revenue exceeding expectations by 211%. Analysts forecast a 65% decline in revenue for 2024 but an improvement in loss per share. The consen...
Voyager Therapeutics, Inc. (NASDAQ:VYGR) is definitely on the radar of institutional investors who own 49% of the company
By Yahoo! Finance |
2 months ago
Ownership research and analyst forecasts data provide insight into stock opportunities. Institutions own 49% of Voyager Therapeutics, indicating strong potential. Hedge funds and Neurocrine Bioscience...